Thyroid Cancer Clinical Trials

30 studies are recruiting for thyroid cancer in the United States right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

By city

Studies, page 2

1. Personalized Treatment in Thyroid Disorders

   The Collar Therapy Indicator (CoTI) (A device that is placed in collar around the neck resembling a turtle neck sweater collar with a wire and recording box) has been shown in a single small previously published experience to provide data regarding radioiodine exposure that correlates with conventi…

   Stage

   Not phased

   Ages

   21 to 65

   Site

   Johns Hopkins Hospital, Baltimore, Maryland

   Run by

   Johns Hopkins University

   See if you can join NCT03517579 on ClinicalTrials.gov

2. APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors

   To assess: * efficacy of APL-101 as monotherapy for the treatment of NSCLC harboring MET Exon 14 skipping mutations, NSCLC harboring MET amplification, solid tumors harboring MET amplification, solid tumors harboring MET fusion, primary CNS tumors harboring MET alterations, solid tumors harboring w…

   Stage

   Phase 2

   Ages

   18 and older

   Site

   Cedars-Sinai Medical Center - Samuel Oschin Comprehensive Cancer Institute, Los Angeles, California

   Locations

   35 in total

   Run by

   Apollomics Inc.

   See if you can join NCT03175224 on ClinicalTrials.gov

3. Assessing Patient Satisfaction and Confidence After Use of Educational Video to Augment Surgical Consent for Thyroid Surgery

   This study looks at how a short educational video can help people better understand thyroid surgery. Patients who have thyroid nodules and need surgery will be part of the study. Some patients will get the usual information from their doctor, while others will also watch a video that explains the s…

   Stage

   Not phased

   Ages

   18 and older

   Site

   Thomas Jefferson University, Philadelphia, Pennsylvania

   Run by

   Thomas Jefferson University

   See if you can join NCT06918223 on ClinicalTrials.gov

4. Restor. I-131 Upt. + Selpercatinib in RET F-P RAI-R TC

   This research is being done to determine the efficacy of selpercatinib to restore radioactive iodine (I-131 NaI) uptake and allow for I-131 treatment in people with RET fusion-positive radioiodine-refractory thyroid cancer. This research study involves the study drug selpercatinib in combination wi…

   Stage

   Phase 2

   Ages

   12 and older

   Site

   MedStar Washington Hospital Center, Washington D.C., District of Columbia

   Locations

   6 in total

   Run by

   Massachusetts General Hospital

   See if you can join NCT05668962 on ClinicalTrials.gov

5. I-124 PET/CT Imaging and Dosimetry for RAI-Naïve or Refractory Thyroid Cancer

   The objective of this study is to demonstrate the clinical utility of I-124 PET/CT imaging and dosimetry in patients with thyroid cancer including 1) Evaluation of extent (volume and pattern) of remnant tissue in post total thyroidectomy setting and distinction of nodal metastases vs remnant tissue…

   Stage

   Not phased

   Ages

   18 and older

   Site

   Miami Cancer Research Center, North Miami, Florida

   Run by

   Miami Cancer Research Center, Inc.

   See if you can join NCT06443866 on ClinicalTrials.gov